[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353162-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353162-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","bcl2-associated-transcription-factor-1-promotes-srchypoxia-inducible-factor-1-subunit-mediated-cancer-stemness-in-radioresistant-triple-negative-breast-cancer","BCL2-Associated Transcription Factor 1 Promotes SRC/Hypoxia-Inducible Factor 1 Subunit α-Mediated Cancer Stemness in Radioresistant Triple-Negative Breast Cancer","","Triple-negative breast cancer shows aggressive behavior and radiotherapy insensitivity, with increased cancer stem cell (CSC) traits that worsen patient outcomes. BCL2-associated transcription factor 1 (BCLAF1) is an oncogenic factor in selected cancers, while its impact on TNBC radioresistance and CSC activity remains unclear. The study analyzes BCLAF1 in TCGA datasets, tests its function in radioresistant MDA-MB-231 cells using SRC overexpression, BCLAF1 knockdown, dasatinib, and HIF-1α inhibition, and measures CSC activity by tumorsphere formation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/bcl2-associated-transcription-factor-1-promotes-srchypoxia-inducible-factor-1-subunit-mediated-cancer-stemness-in-radioresistant-triple-negative-breast-cancer/353162/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/bcl2-associated-transcription-factor-1-promotes-srchypoxia-inducible-factor-1-subunit-mediated-cancer-stemness-in-radioresistant-triple-negative-breast-cancer/353162.png","ImageObject",300,407,{"name":42,"@type":43},"Kurz","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about BCLAF1 in triple-negative breast cancer?","Question",{"text":63,"@type":64},"The study investigates BCLAF1’s involvement in TNBC radioresistance and cancer stem cell (CSC) activity, addressing a gap in understanding the molecular basis for CSC-driven radiation survival and recurrence.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were clinical relevance and gene expression assessed?",{"text":68,"@type":64},"BCLAF1 expression and clinical significance were analyzed using the TCGA breast cancer dataset.",{"name":70,"@type":61,"acceptedAnswer":71},"Which experimental approaches were used to test the regulatory mechanism?",{"text":72,"@type":64},"Radioresistant MDA-MB-231 cells were used with SRC overexpression, BCLAF1 knockdown, dasatinib treatment, and HIF-1α inhibition to evaluate effects on radioresistance and stemness-related pathways.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353162,1790145480,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},2336478945635,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","| [http://doi.org/10.32604/or.2026.080978](http://doi.org/10.32604/or.2026.080978) |  |\n| --- | --- |\n|  | |\n| ARTICLE\u003Cbr>BCL2-Associated Transcription Factor 1 Promotes SRC/Hypoxia-Inducible Factor 1 Subunit α-Mediated Cancer Stemness in Radioresistant\u003Cbr>Triple-Negative Breast Cancer\u003Cbr>Yu-Hao Huang 1,\\# , Hao-Yeh Chen2,\\# , Peng-Ju Chien1 , Chun-Yu Chen2,3 , Shao-Ti Li4 , Hsueh-Te Lee5 , Yueh-Chun Lee4,6,* and Wen-Wei Chang1,7, *\u003Cbr>1Department of Biomedical Sciences, Chung Shan Medical University, Taichung, Taiwan\u003Cbr>2Department of Emergency Medicine, Tungs’Taichung MetroHarbor Hospital, Taichung, Taiwan\u003Cbr>3Post-Baccalaureate Medicine, National Chung Hsing University, Taichung, Taiwan\u003Cbr>4Department of Radiation Oncology, Chung Shan Medical University Hospital, Taichung, Taiwan\u003Cbr>5Institute of Anatomy & Cell Biology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan\u003Cbr>6School of Medicine, Chung Shan Medical University, Taichung, Taiwan\u003Cbr>7Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan\u003Cbr>*Corresponding Authors: Yueh-Chun Lee. Email: [lee.yuehchun@gmail.com](lee.yuehchun@gmail.com); Wen-Wei Chang. Email: [changww@csmu.edu.tw](changww@csmu.edu.tw)\u003Cbr>[\\#](# These authors contributed equally to this work)[ These authors contributed equally to this work](# These authors contributed equally to this work)\u003Cbr>Received: 20 February 2026; Accepted: 22 April 2026; Published: 16 June 2026\u003Cbr>ABSTRACT: Backgrounds: Triple-negative breast cancer (TNBC) is highly aggressive, insensitive to radiotherapy, and exhibits increased cancer stem cell (CSC) properties, contributing to poor patient outcomes. B-cell lymphoma 2 (BCL2) associated transcription factor 1 (BCLAF1) is an oncogene in certain cancers, but its role in TNBC is unclear. This study investigated BCLAF1’s involvement in radioresistance and CSC activity in TNBC. Methods: BCLAF1 expression and clinical significance were analyzed using The Cancer Genome Atlas (TCGA) breast cancer dataset. Radioresistant MDA-MB-231 cells were used to examine BCLAF1’s function. Proto-oncogene SRC (SRC) overexpression, BCLAF1 knockdown, dasatinib treatment, and hypoxia inducible factor 1 subunit α (HIF-1α) inhibition were employed to elucidate regulatory mechanisms. CSC activity was assessed using tumorsphere formation assays Results: Elevated BCLAF1 mRNA levels were associated with advanced pathological and T stages (analysis of variance [ANOVA], p = 1 .4 × 10−3) and poorer overall survival by Kaplan–Meier analysis (p = 0 .021) . BCLAF1 expression was positively correlated with SRC signaling pathway-associated genes, including Kirsten rat sarcoma viral oncogene homolog (KRAS), GTPase-activating protein-binding protein 1 (G3BP1), and phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1) . Radioresistant cells exhibited higher BCLAF1 expression. SRC overexpression reduced radiosensitivity, while increasing BCLAF1 levels. BCLAF1 knockdown suppressed tumorsphere formation. Dasatinib decreased BCLAF1, HIF-1α, and stemness proteins, including octamer-binding transcription factor 4 (OCT-4), Notch intracellular domain (NICD), and cellular myelocytomatosis oncogene (c-Myc) . BCLAF1 knockdown diminished nuclear HIF-1α, and HIF-1α inhibition abrogated BCLAF1-induced tumorsphere formation. Conclusions: BCLAF1 enhances radioresistance and CSC properties in TNBC via SRC-HIF-1α signaling, suggesting that BCLAF1 is a potential therapeutic target to overcome radioresistance in TNBC.\u003Cbr>KEYWORDS: B-cell lymphoma 2 (BCL2) associated transcription factor 1; SRC kinase; hypoxia-inducing factor 1subunit α; triple negative breast cancer; cancer stemness; radiation response |  |\n\nCopyright © 2026 The Authors. Published by Tech Science Press. This work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ","cbCaioWbRBMEJvA3","https://ap.wps.com/l/cbCaioWbRBMEJvA3","pdf",5861213,"English","# Abstract\n# Introduction","[{\"question\":\"What question does the study address about BCLAF1 in triple-negative breast cancer?\",\"answer\":\"The study investigates BCLAF1’s involvement in TNBC radioresistance and cancer stem cell (CSC) activity, addressing a gap in understanding the molecular basis for CSC-driven radiation survival and recurrence.\"},{\"question\":\"How were clinical relevance and gene expression assessed?\",\"answer\":\"BCLAF1 expression and clinical significance were analyzed using the TCGA breast cancer dataset.\"},{\"question\":\"Which experimental approaches were used to test the regulatory mechanism?\",\"answer\":\"Radioresistant MDA-MB-231 cells were used with SRC overexpression, BCLAF1 knockdown, dasatinib treatment, and HIF-1α inhibition to evaluate effects on radioresistance and stemness-related pathways.\"}]","BCL2-Associated Transcription Factor 1 Promotes SRC/Hypoxia-Inducible Factor 1 Subunit α-Mediated Cancer Stemness in Radioresistant Triple-Negative Breast Cancer | PDF",1790103364,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b5fe1df118256e8c277b33df0b69c1e.webp",983,1272,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/622fd4f73507fef31dbe7be4c0e1ade3.webp",982,1270,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/15f2f48c2f374314a7f550985d386df0.webp",981,1269,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7644c4603134ee8b1dd21d5a52f39933.webp",980,1268]